Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials

被引：0
|
作者：
Durgam, S. [1 ]
Earley, W. [1 ]
Lu, K. [1 ]
Nemeth, G. [2 ]
Laszlovszky, I. [2 ]
Szatmari, B. [2 ]
Edwards, J. [1 ]
Nasrallah, H. A. [3 ,4 ]
机构：
[1] Forest Res Inst, Clin Dev, Jersey City, NJ USA
[2] Gedeon Richter Plc, Med Div, Budapest, Hungary
[3] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA
[4] St Louis Univ, Dept Psychiat, St Louis, MO 63103 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
ACUTE EXACERBATION;
D O I：
10.1016/S0924-977X(16)31598-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.039
引用
收藏
页码：S552 / S552
页数：1
相关论文
共 50 条
  • [1] Cariprazine for Negative Symptoms of Schizophrenia: Pooled Post Hoc Analysis of 2 Randomized, Double-Blind, Placebo- and Active-Controlled Trials
    Earley, Willie
    Durgam, Suresh
    Debelle, Marc
    Laszlovszky, Istvan
    Lu, Kaifeng
    Nasrallah, Henry
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S233 - S234
  • [2] TRAJECTORY OF CARIPRAZINE TREATMENT EFFECTS ACROSS SCHIZOPHRENIA SYMPTOMS: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL
    Cutler, Andrew J.
    Durgam, Suresh
    Lu, Kaifeng
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Meltzer, Herbert Y.
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S308 - S308
  • [3] Efficacy of Cariprazine Across Schizophrenia Symptoms: A Post Hoc Analysis of PANSS Data from a Phase III, Double-blind, Placebo- and Active-controlled Trial
    Zukin, Stephen R.
    Lieberman, Jeffrey A.
    Cutler, Andrew J.
    Lu, Kaifeng
    Migliore, Raffaele
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Durgam, Suresh
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S379 - S380
  • [4] Cariprazine in negative symptoms of schizophrenia: post hoc analyses of a fixed-dose, placebo- and active-controlled trial
    Debelle, M.
    Faradzs-zade, S.
    Szatmari, B.
    Nagy, K.
    Nemeth, G.
    Durgam, S.
    Laszlovszky, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S534 - S534
  • [5] Cariprazine in Negative Symptoms of Schizophrenia: Post-hoc Analyses of a Fixed-dose Phase Iii, Randomized, Double-blind, Placebo-and Active-controlled Trial
    Debelle, M.
    Faradzs-zade, S.
    Szatmari, B.
    Nagy, K.
    Nemeth, G.
    Durgam, S.
    Laszlovszky, I.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [6] Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial
    Durgam, Suresh
    Cutler, Andrew J.
    Lu, Kaifeng
    Migliore, Raffaele
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Meltzer, Herbert Y.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (12) : E1574 - +
  • [7] Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, randomised, double-blind, placebo- and active-controlled trial
    Lieberman, J. A.
    Cutler, A. J.
    Wan, S.
    Migliore, R.
    Ruth, A.
    Laszlovszky, I.
    Nemeth, G.
    Durgam, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S477 - S478
  • [8] EFFECTS OF CARIPRAZINE ON NEGATIVE SYMPTOMS, COGNITIVE IMPAIRMENT, AND PROSOCIAL FUNCTIONING IN PATIENTS WITH PREDOMINANT NEGATIVE SYMPTOMS: POST HOC ANALYSIS OF A PHASE III, PLACEBO-, AND ACTIVE-CONTROLLED STUDY
    Daniel, David
    Nasrallah, Henry
    Earley, Willie
    Durgam, Suresh
    Lu, Kaifeng
    Szatmari, Balazs
    Laszlovszky, Istvyn
    Nemeth, Gyorgy
    Patel, Mehul
    [J]. SCHIZOPHRENIA BULLETIN, 2017, 43 : S13 - S13
  • [9] Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials
    Dombi, Z. B.
    Acsai, K.
    Barabassy, A.
    Sebe, B.
    Laszlovszky, I.
    Vass, G.
    Szatmari, B.
    Patel, M.
    Earley, W.
    Nemeth, G.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S524 - S525
  • [10] Efficacy of cariprazine in the early stage of schizophrenia: a pooled, post-hoc analysis of 3 phase II/III double-blind placebo-controlled trials
    Dombi, Z. B.
    Acsai, K.
    Barabassy, A.
    Sebe, B.
    Laszlovszky, I.
    Vass, G.
    Szatmari, B.
    Patel, M.
    Earley, W.
    Nemeth, G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S325 - S326
12345